MBAA: America Should Lead in Medicine, Not Import Foreign Price Controls
Alanna Temme, President of Midsized Biotech Alliance of America, released the following statement on the introduction of H.R. 7837, the Most Favored Patient Act of 2026, which threatens midsized biotech innovation…